Home > Healthcare > Medical Devices > U.S. Vitrification Market

U.S. Vitrification Market Share

Report ID: GMI10251
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

U.S. Vitrification Market Share

The U.S. vitrification industry is characterized by a diverse range of companies offering advanced freezing and preservation technologies for biological specimens such as embryos, oocytes, and sperm. The key competitive factors include technological innovation in vitrification devices, efficacy of cryopreservation techniques, and geographic market reach. Also, strategic partnerships with fertility clinics and research institutions enhance market penetration.

U.S. Vitrification Market Companies

Prominent players operating in the U.S. vitrification industry are as mentioned below:

Biotech, Inc.
CooperSurgical Fertility Company
FERTIPRO NV
FUJIFILM Irvine Scientific
Genea BIOMEDX
IMV Technologies Group (Cryo Bio System)
Kitazato Corporation.
MFC Global
MINITÜB GMBH
NidaCon International AB
Optimas
Shenzhen VitaVitro Biotech
Vitrolife

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. vitrification market size was USD 3.4 billion in 2023 and is expected to register 9.8% CAGR from 2024-2032 owing to the increasing infertility rates that surged the demand for advanced fertility treatments in the country.

The devices segment reached USD 1.5 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its pivotal role in rapidly freezing biological specimens for preservation.

Northeast zone vitrification industry is expected to register 9.2% CAGR from 2024-2032 due to a significant presence of advanced medical facilities and research centers focused on reproductive health in the states.

FERTIPRO NV, FUJIFILM Irvine Scientific, Genea BIOMEDX, IMV Technologies Group (Cryo Bio System), Kitazato Corporation., MFC Global, MINIT